Drug Search Results

Fispemifene

Alternative Names: fispemifene
Latest Update: 2024-05-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ER Modulator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: QuatRx Company
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fispemifene

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Erectile Dysfunction|Hypogonadism|Chronic Obstructive Pulmonary Disease

Trial	Phase	Trial Status	Disease	Primary Completion Date
NM-F15-202	P2	Unknown status	Erectile Dysfunction\|Hypogonadism	2015-10-01
NCT00415571	P2	Completed	Erectile Dysfunction\|Hypogonadism	None
NCT01061970	P2	Completed	Chronic Obstructive Pulmonary Disease\|Hypogonadism	None
NCT00290134	P2	Completed	Hypogonadism	None

Recent News Events

Date	Type	Title
05/01/2024	PubMed	Vulvovaginal atrophy in women with and without a history of breast cancer: Baseline data from the PatiEnt satisfactiON studY (PEONY) in Italy.
03/04/2024	PubMed	Drugs for menopausal symptoms.
11/19/2023	PubMed	Novel Advances in the Role of Selective Estrogen Receptor Modulators in Hormonal Replacement Therapy: A Paradigm Shift.
12/11/2019	News Article	Forendo Pharma Signs Important License and Collaboration Deal with Leading Pharma Company
08/20/2019	News Article	Forendo Pharma Commences Phase 1b Proof of Mechanism Study with its Lead Endometriosis Program, HSD17B1 Inhibitor FOR-6219
07/19/2019	News Article	Sunstone Life Science Ventures Joins Forendo Pharma Investor Syndicate
06/27/2019	News Article	Hypogonadism Market Spotlight 2019 - Clinical Trial Activity is Dominated by Completed Trials, and AbbVie Leads with 8 Completed Trials

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions